Data as of Aug 29
| +0.10 / +1.08%|
The 5 analysts offering 12-month price forecasts for Heron Therapeutics Inc have a median target of 18.00, with a high estimate of 40.00 and a low estimate of 18.00. The median estimate represents a +91.69% increase from the last price of 9.39.
The current consensus among 5 polled investment analysts is to Buy stock in Heron Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.